Wedbush Tesla · TSLA

Wedbush Reiterates Outperform on Tesla, $550 Price Target

Analyst: Daniel Ives 1 min read Reproduced verbatim
Rating
Outperform
Unchanged
Target
$550
Outcome
Missed
within 12 months
Wedbush and Tesla logos

What the analyst said

Wedbush analyst Daniel Ives reiterated an Outperform rating and $550 price target on Tesla (NASDAQ: TSLA)

“There have been a number of times in the Tesla story over the past decade that negative sentiment and Street worries have overshadowed the narrative of this unique disruptive global tech story.

From the white knuckle production moments in 2017/2018 to financing worries to the Musk/Twitter soap opera in 2022…and now here again Tesla bulls find themselves with their back against the wall facing global negative sentiment around Musk/DOGE and the Trump Administration.

This is a gut check moment for the Tesla bulls (including ourselves) after this massive sell-off in Tesla shares with fears mounting.

The bears own the Tesla narrative in the near-term as lackluster sales numbers from Europe, China, and the US in January/February along with Musk protests/brand worries have created many concerns.While the DOGE/Trump Musk iron clad partnership has created major brand worries for Tesla….we estimate less than 5% of Tesla sales globally are at risk from these issues despite the global draconian narrative for Musk.

Importantly, we expect Musk will better balance his time between DOGE and Tesla/SpaceX over the course of 2025 and some of these distraction issues will fade.

We continue to believe the best thing that ever happened to Musk and Tesla was Trump in the White House as this will create a deregulatory environment with a federal autonomous roadmap central to the Tesla golden strategic vision.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

TSLA trades at $358. The 17 analysts who set a target in the last 3 months range from $24.86 to $500, with a median of $442. This $550 target is 24% above the median, the highest on the Street.

Since the note TSLA has moved +36% (from $263). The 12-month window closed on March 7, 2026.

Track record

This call✗ Not reached within 12 months: a year after the note TSLA closed at $449, 18% below the $550 target, but it moved the way the analyst expected. Same target as this firm’s January 22, 2025 note, so it is scored there.

Firm track recordWedbush: 65% of its 23 targets at least a year old were reached within 12 months (#20 of 26 firms); on Tesla, 2 of 8. Accuracy ranking →

Wedbush on Tesla

Wedbush price targets on Tesla

8 calls from September 5, 2025 to April 2, 2026. The target went from $500 to $600 (+20%). The rating stayed Buy.

Wedbush targetTSLA share price
  1. April 2, 2026Kept the $600 targetBuy$600
  2. January 2, 2026Kept the $600 targetBuy$600
  3. December 15, 2025Kept the $600 targetBuy$600
  4. October 23, 2025Kept the $600 targetBuy$600
  5. October 20, 2025Kept the $600 targetBuy$600
  6. October 7, 2025Kept the $600 targetBuy$600
  7. September 26, 2025Target raised from $500 (+20%)Buy$600
  8. September 5, 2025Earliest call shownBuy$500
Share

Other analysts on Tesla

CantorBuy Kept rating and price target Oct 26 $485maintained BarclaysBuy Upgraded, raised price target +22% Oct 26 $450from $370 StoneXBuy Kept rating and price target Oct 22 $475maintained BNP ParibasHold Upgraded Oct 22 Morgan StanleyHold Raised price target +2%, kept rating Oct 22 $410from $400
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.